Loading clinical trials...
Loading clinical trials...
Prospective randomized clinical study comparing SIGNUS MOBIS PEEK vs SIGNUS MOBIS II ST in patients with Degenerative Disc Disease at one or two contiguous levels from L2-S1
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Signus Medizintechnik GmbH
NCT04641039 · Lumbar Disc Disease
NCT06825390 · Low Back Pain, Chronic Low-back Pain, and more
NCT05299762 · Intervertebral Disc Degeneration, Spinal Fusion, and more
NCT03060434 · Lumbar Radiculopathy, Lumbar Disc Herniation, and more
NCT02192112 · Degenerative Lumbar Disc Disease
Upstate Orthopedics
East Syracuse, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions